Q9967 — Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
37,147,519 observed fee-for-service (51%) · ~35,837,780 estimated Medicare Advantage. Scaled from the observed floor by each state’s fee-for-service share (FFS share as of 2023) — scaled estimate — assumes MA utilization mirrors FFS; not an observation; 1 state without payer-mix data excluded. How we scale
Disclosed Medicare fee-for-service services by billing state; open a bar for that state's ranked market. Average submitted charge / service by billing state, among the highest-volume states; open a bar for that state's ranked market.
- Market position — where this market sits on volume and growth among all state markets, and its rank.
- Worth a look — every state market for this search, ranked by a published score: size, growth, fragmentation, below-expected volume.
- Lookalike opportunities — groups billing below what peers of the same specialty, size, and state predict, with the expected figure shown.
- National benchmarks — where each group's volume sits nationally and within its specialty.
- Market structure — how concentrated this market is, and who owns the volume.
- Medicare-wide scaling — the exact payer split, and this market total scaled to all of Medicare, labeled as an estimate.
Nevvi's market analytics platform — code baskets, market structure and share, the twelve-year trend layer — is built and not launched yet. We're gathering interest in it.
Notify me at launch →Specialty market — Hematology/Oncology: 3,151,208 services across 27 groups; top group 29%. See Hematology/Oncology across all states →
| # | Physician group | City | St | Specialty | Providers | Q9967 svcs | Submitted charges | Avg charge | Medicare $ locked column | Share of specialty* | Share of state* | Phone |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | FLORIDA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC | FORT MYERS | FL | HEMATOLOGY/ONCOLOGY | 437 | 914,512 | $914,512 | $1 | premium | — | 8.1% | (239) 561-9622 |
| 2 | CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE INC | LITTLE ROCK | AR | HEMATOLOGY/ONCOLOGY | 90 | 426,631 | $853,578 | $2 | premium | — | 34.9% | — |
| 3 | IRONWOOD PHYSICIANS PC | MESA | AZ | HEMATOLOGY/ONCOLOGY | 114 | 355,459 | $355,459 | $1 | premium | — | 8.6% | (480) 981-1326 |
| 4 | SOUTH CAROLINA ONCOLOGY ASSOC PA | COLUMBIA | SC | HEMATOLOGY/ONCOLOGY | 18 | 198,916 | $105,425 | $1 | premium | — | 10.6% | (803) 461-3000 |
| 5 | CANCER SPECIALISTS LLC | JACKSONVILLE | FL | HEMATOLOGY/ONCOLOGY | 46 | 179,750 | $179,750 | $1 | premium | — | 1.6% | (904) 516-3737 |
| 6 | TENNESSEE ONCOLOGY PLLC | NASHVILLE | TN | HEMATOLOGY/ONCOLOGY | 360 | 177,956 | $177,956 | $1 | premium | — | 5.1% | (615) 385-3751 |
| 7 | CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS SC | DECATUR | IL | HEMATOLOGY/ONCOLOGY | 30 | 159,330 | $497,110 | $3 | premium | — | 5.6% | (217) 876-4700 |
| 8 | CALIFORNIA CANCER ASSOCIATES FOR RESEARCH AND EXCELLENCE INC | FRESNO | CA | HEMATOLOGY/ONCOLOGY | 62 | 90,151 | $90,151 | $1 | premium | — | 0.9% | (559) 326-1222 |
| 9 | EPIC CARE | PLEASANT HILL | CA | HEMATOLOGY/ONCOLOGY | 54 | 82,790 | $193,062 | $2 | premium | — | 0.8% | (925) 687-2570 |
| 10 | RAVI PATEL M D INC | BAKERSFIELD | CA | HEMATOLOGY/ONCOLOGY | 20 | 62,280 | $62,280 | $1 | premium | — | 0.6% | (661) 322-2206 |
| 11 | AMERICAN ONCOLOGY PARTNERS PA | FORT WAYNE | AR | HEMATOLOGY/ONCOLOGY | 333 | 60,801 | $60,801 | $1 | premium | — | 5.0% | (260) 484-8830 |
| 12 | AUGUSTA ONCOLOGY ASSOCIATES PC | AUGUSTA | GA | HEMATOLOGY/ONCOLOGY | 36 | 53,103 | $53,103 | $1 | premium | — | 3.8% | 7067361830213 |
| 13 | MAINE CENTER FOR CANCER MEDICINE AND BLOOD DISORDERS PA | WESTBROOK | ME | HEMATOLOGY/ONCOLOGY | 69 | 45,141 | $136,976 | $3 | premium | — | 30.1% | (207) 303-3300 |
| 14 | HEM ONC ASSOCIATES OF THE TREASURE COAST, PA | PORT SAINT LUCIE | FL | HEMATOLOGY/ONCOLOGY | 6 | 41,750 | $50,100 | $1 | premium | — | 0.4% | (772) 335-5666 |
| 15 | CANCER SPECIALISTS LLC | JACKSONVILLE | XX | HEMATOLOGY/ONCOLOGY | 46 | 33,000 | $33,000 | $1 | premium | — | 100.0% | (904) 516-3737 |
| 16 | AMERICAN ONCOLOGY PARTNERS PA | FORT WAYNE | GA | HEMATOLOGY/ONCOLOGY | 333 | 31,230 | $31,230 | $1 | premium | — | 2.2% | (260) 484-8830 |
| 17 | AMERICAN ONCOLOGY PARTNERS PA | FORT WAYNE | OH | HEMATOLOGY/ONCOLOGY | 333 | 28,435 | $28,435 | $1 | premium | — | 2.8% | (260) 484-8830 |
| 18 | CAROLINA BLOOD AND CANCER CARE ASSOCIATES PA | ROCK HILL | SC | HEMATOLOGY/ONCOLOGY | 8 | 28,005 | $28,005 | $1 | premium | — | 1.5% | (803) 329-7772 |
| 19 | AMERICAN ONCOLOGY PARTNERS PA | FORT WAYNE | NC | HEMATOLOGY/ONCOLOGY | 333 | 26,555 | $26,555 | $1 | premium | — | 0.8% | (260) 484-8830 |
| 20 | MID-FLORIDA CANCER CENTERS LLC | ORANGE CITY | FL | HEMATOLOGY/ONCOLOGY | 13 | 24,291 | $7,287 | $0 | premium | — | 0.2% | (386) 774-1223 |
| 21 | AMERICAN ONCOLOGY PARTNERS PA | FORT WAYNE | IN | HEMATOLOGY/ONCOLOGY | 333 | 23,901 | $23,901 | $1 | premium | — | 3.6% | (260) 484-8830 |
| 22 | EAST TEXAS HEMATOLOGY AND ONCOLOGY | LUFKIN | TX | HEMATOLOGY/ONCOLOGY | 5 | 14,111 | $12,997 | $1 | premium | — | 0.2% | (936) 637-6415 |
| 23 | MICHAEL P SHERMAN MD PHD A MEDICAL CORPORATION | WALNUT CREEK | CA | HEMATOLOGY/ONCOLOGY | 13 | 14,101 | $14,101 | $1 | premium | — | 0.1% | (925) 939-9610 |
| 24 | AMERICAN ONCOLOGY PARTNERS PA | FORT WAYNE | TX | HEMATOLOGY/ONCOLOGY | 333 | 13,100 | $3,952 | $0 | premium | — | 0.2% | (260) 484-8830 |
| 25 | ILLINOIS CANCER SPECIALISTS | ARLINGTON HEIGHTS | IL | HEMATOLOGY/ONCOLOGY | 29 | 11,703 | $35,109 | $3 | premium | — | 0.4% | (847) 259-4482 |
| 26 | NEVADA ONCOLOGY SPECIALISTS TOY GOODMAN SAMLOWSKI PC | LAS VEGAS | NV | HEMATOLOGY/ONCOLOGY | 2 | 10,700 | $32,100 | $3 | premium | — | 1.1% | (702) 473-1757 |
| 27 | FLORIDA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC | FORT MYERS | IL | HEMATOLOGY/ONCOLOGY | 437 | 10,620 | $15,930 | $2 | premium | — | 0.4% | (239) 561-9622 |
| 28 | KATMAI ONCOLOGY GROUP LLC | ANCHORAGE | AK | HEMATOLOGY/ONCOLOGY | 11 | 7,480 | $12,267 | $2 | premium | — | 1.9% | (907) 562-0321 |
| 29 | MARY BIRD PERKINS CANCER CENTER | BATON ROUGE | LA | HEMATOLOGY/ONCOLOGY | 82 | 5,925 | $5,925 | $1 | premium | — | 0.9% | (225) 767-0847 |
| 30 | MCALLEN ONCOLOGY PA | MCALLEN | TX | HEMATOLOGY/ONCOLOGY | 2 | 5,400 | $5,400 | $1 | premium | — | 0.1% | (956) 217-7000 |
| 31 | CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS SC | DECATUR | WI | HEMATOLOGY/ONCOLOGY | 30 | 3,700 | $11,544 | $3 | premium | — | 0.3% | (217) 876-4700 |
| 32 | VIRGINIA CANCER SPECIALISTS, P.C. | FAIRFAX | VA | HEMATOLOGY/ONCOLOGY | 76 | 3,564 | $10,692 | $3 | premium | — | 0.1% | (703) 280-5390 |
| 33 | TENNESSEE ONCOLOGY PLLC | NASHVILLE | WA | HEMATOLOGY/ONCOLOGY | 360 | 2,500 | $2,500 | $1 | premium | — | 0.1% | (615) 385-3751 |
| 34 | NORTHWEST CANCER CENTERS PC | DYER | IN | HEMATOLOGY/ONCOLOGY | 26 | 2,400 | $14,400 | $6 | premium | — | 0.4% | (812) 220-4476 |
| 35 | COMPREHENSIVE HEMATOLOGY ONCOLOGY LLC | TRINITY | FL | HEMATOLOGY/ONCOLOGY | 18 | 1,900 | $972 | $1 | premium | — | 0.0% | (727) 344-6569 |
| 36 | ONCOLOGY HEMATOLOGY CONSULTANTS, PA | FORT WORTH | TX | HEMATOLOGY/ONCOLOGY | 69 | 17 | $13 | $1 | premium | — | 0.0% | (817) 759-7000 |
*"Share of specialty" is the group's share of disclosed Medicare-FFS services for the primary code among groups with the SAME modal specialty in the state; "share of state" is the same figure against the whole state. Specialty is each group's modal member specialty from CMS's clinician register — a multi-specialty group carries one label. Where fewer than 11 groups share the specialty in the state, the specialty share renders "—" — the specialty benchmark is suppressed (fewer than 11 groups) and the state share alongside is the benchmark. Group figures sum clinicians affiliated with exactly one group. See Methods.
Comparing against an all-payer estimate?
These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →